Publications by authors named "Cornelia Tillack"

Claim this Profile
D
Development of a uniform, very aggressive disease phenotype in all homozygous carriers of the NOD2 mutation p.Leu1007fsX1008 with Crohn's disease and active smoking status resulting in ileal stenosis requiring surgery.
Fabian Schnitzler, Matthias Friedrich, Marianne Angelberger, Julia Diegelmann, Johannes Stallhofer, Cornelia Tillack

PLoS One· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes with ustekinumab as rescue treatment in therapy-refractory or therapy-intolerant ulcerative colitis.
Thomas Ochsenkühn, Cornelia Tillack, Daniel Szokodi, Shorena Janelidze, Fabian Schnitzler

United European Gastroenterol J· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A short and pragmatic guide through diagnostics and therapies of chronic inflammatory bowel diseases].
Thomas Ochsenkühn, Daniel Szokodi, Cornelia Tillack

MMW Fortschr Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort.
Fabian Schnitzler, Matthias Friedrich, Johannes Stallhofer, Ulf Schönermarck, Michael Fischereder, Cornelia Tillack

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NOD2 Single Nucleotide Polymorphism rs72796353 (IVS4+10 A>C) Is a Predictor for Perianal Fistulas in Patients with Crohn's Disease in the Absence of Other NOD2 Mutations.
Fabian Schnitzler, Matthias Friedrich, Christiane Wolf, Johannes Stallhofer, Marianne Angelberger, Cornelia Tillack

PLoS One· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NOD2 p.Leu1007fsX1008 mutation (rs2066847) is a stronger predictor of the clinical course of Crohn's disease than the FOXO3A intron variant rs12212067.
Fabian Schnitzler, Matthias Friedrich, Christiane Wolf, Marianne Angelberger, Julia Diegelmann, Cornelia Tillack

PLoS One· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease.
Matthias Friedrich, Cornelia Tillack, Andreas Wollenberg, Jürgen Schauber, Stephan Brand

Inflamm Bowel Dis· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies.
Florian Beigel, Anni Steinborn, Fabian Schnitzler, Cornelia Tillack, Simone Breiteneicher

Pharmacoepidemiol Drug Saf· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
Cornelia Tillack, Laura Maximiliane Ehmann, Matthias Friedrich, Rüdiger P Laubender, Pavol Papay

Gut· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTPN2 gene variants are associated with susceptibility to both Crohn's disease and ulcerative colitis supporting a common genetic disease background.
Jürgen Glas, Johanna Wagner, Julia Seiderer, Torsten Olszak, Martin Wetzke, Cornelia Tillack

PLoS One· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of IL12B gene variants in inflammatory bowel disease.
Jürgen Glas, Julia Seiderer, Johanna Wagner, Torsten Olszak, Christoph Fries, Cornelia Tillack

PLoS One· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease.
Florian Beigel, Beate Löhr, Rüdiger P Laubender, Cornelia Tillack, Fabian Schnitzler

Digestion· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease.
Jürgen Glas, Julia Seiderer, Corinna Bayrle, Martin Wetzke, Christoph Fries, Cornelia Tillack

PLoS One· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional SFTPD gene variants are not associated with susceptibility to inflammatory bowel disease in the German population.
Jürgen Glas, Julia Seiderer, Cornelia Tillack, Ekaterini Paschos, Martin Wetzke

Inflamm Bowel Dis· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CEACAM6 gene variants in inflammatory bowel disease.
Jürgen Glas, Julia Seiderer, Christoph Fries, Cornelia Tillack, Simone Pfennig

PLoS One· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NOD2 single nucleotide polymorphisms rs2066843 and rs2076756 are novel and common Crohn's disease susceptibility gene variants.
Jürgen Glas, Julia Seiderer, Cornelia Tillack, Simone Pfennig, Florian Beigel

PLoS One· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of adalimumab in Crohn's disease during pregnancy: case report and review of the literature.
Matthias Jürgens, Stephan Brand, Levent Filik, Christoph Hübener, Uwe Hasbargen, Cornelia Tillack

Inflamm Bowel Dis· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis.
Matthias Jürgens, Rüdiger P Laubender, Franziska Hartl, Maria Weidinger, Julia Seiderer, Cornelia Tillack

Am J Gastroenterol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The presence of fistulas and NOD2 homozygosity strongly predict intestinal stenosis in Crohn's disease independent of the IL23R genotype.
Matthias Jürgens, Stephan Brand, Rüdiger P Laubender, Julia Seiderer, Jürgen Glas, Cornelia Tillack

J Gastroenterol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatosplenic T-cell lymphoma in a patient with Crohn's disease.
Florian Beigel, Matthias Jürgens, Cornelia Tillack, Marion Subklewe, Doris Mayr

Nat Rev Gastroenterol Hepatol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population.
Jürgen Glas, Julia Seiderer, Giulia Pasciuto, Cornelia Tillack, Julia Diegelmann

Am J Gastroenterol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of magnetic resonance enteroclysis (MRE) and wireless capsule endoscopy (CE) in the diagnosis of small bowel lesions in Crohn's disease.
Cornelia Tillack, Julia Seiderer, Stephan Brand, Burkhard Göke, Maximilian F Reiser

Inflamm Bowel Dis· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
Julia Seiderer, Ira Elben, Julia Diegelmann, Jürgen Glas, Johannes Stallhofer, Cornelia Tillack

Inflamm Bowel Dis· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease.
Julia Seiderer, Julia Dambacher, Dorothea Leistner, Cornelia Tillack, Jürgen Glas

Clin Immunol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCL16 is a surrogate marker of inflammatory bowel disease.
Michael Lehrke, Astrid Konrad, Veronika Schachinger, Cornelia Tillack, Frank Seibold

Scand J Gastroenterol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis